4.91B
Market cap
34.03x
Current P/E
30.58x
Forward P/E

About

Health care
Sector
Diagnostics & Research
Industry

DiaSorin S.p. A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample.

Similar securities

Based on sector and market capitalization

Report issue